Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 253

The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.

Aspirin and other antiplatelet agents in the secondary and primary prevention of cardiovascular disease.

Open access
Hennekens, C H, Buring, J E, Sandercock, P, Collins, R, Peto, R · 1989 · Circulation

Abstract

A ntiplatelet therapy, particularly with aspirin, has become the focus of much research in the treatment and prevention of cardiovascular disease.In this paper, we review the evidence of efficacy; first, for patients who have a history of myocardial infarction (M1), stroke, tran- sient cerebral ischemia (TCI), or unstable angina; second, for those actually undergoing acute myo- cardial infarction (AMI); and, finally, for appar- ently healthy individuals.Mechanism of Action of Aspinin Aspirin permanently inhibits cyclooxygenasedependent platelet aggregation.1-8Even low dose aspirin (e.g., 80 mg/day) will, within a few days, inhibit platelet cyclooxygenase so completely that little further effect on this mechanism of platelet aggregation would be expected at higher daily doses of the drug,3'6'8 although, if antiplatelet therapy is to be started during an acute vascular event, such as MI, then a somewhat higher loading dose (at least 160 mg) might be preferred to ensure a rapid antithrombotic effect.During the past 20 years, there have been reports from observational epidemiologic studies of aspirin as well as a number of randomized trials.Taken as a whole, the case-control and cohort studies suggest that aspirin may reduce the incidence of cardiovas- cular disease by about 20%,9-12 which, if true, would be clinically worthwhile and would have an important impact on public health.Unfortunately, however, the amount of uncontrolled confounding inherent in such observational studies could be about as great as the postulated benefit.13In gen- eral, reliable assessment of such modest benefits can be derived only from large randomized trials.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/01.cir.80.4.749

Cites

24 of 24 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 253

Metadata

Authors
Hennekens, C. H., Buring, J. E., Sandercock, P., Collins, R., & Peto, R.
Venue
Circulation
Published
1989-10
Volume
80
Issue
4
Pages
749-756
ISSN
  • 0009-7322 (ISSN-L)
  • 1524-4539
OpenAlex
W2052000438
Cited by
253
References
24
FWCI
19.26
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.